Nutrition is the cornerstone to lasting health and weight management.
What happens when the GLP-1 medications wear off? Few other drugs have hit the market with the speed and ferocity of the GLP-1 weight loss medications. The rapid increase in users has led to an estimated 1.5 to 1.6 million people in the UK using either Wegovy (semaglutide) or Mounjaro (tirzepatide) for weight management, with 95% accessing them privately (1). This last point is cause for great concern. With so many people accessing these medications privately there is no governance for safe dosing or the necessary wraparound care and support needed to ensure patient safety. The remaining......
















































































































